100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
BLOCK 3 PMY 302 - DRUGS to KNOW QUESTIONS WITH COMPLETE ANSWERS $7.99   Add to cart

Exam (elaborations)

BLOCK 3 PMY 302 - DRUGS to KNOW QUESTIONS WITH COMPLETE ANSWERS

 8 views  0 purchase
  • Course
  • BLOCK 3 PMY 302 - DRUGS to KNOW
  • Institution
  • BLOCK 3 PMY 302 - DRUGS To KNOW

Desmopressin MOA - activates V2 receptors in the kidney's collecting ducts, reabsorbing water into plasma and concentrating the urine (prevents water from leaving the body) Octreotide Acetate and Lanreotide Therapeutic effects - suppresses GH hypersecretions, reduces pituitary adenoma overgrowth...

[Show more]

Preview 4 out of 32  pages

  • September 1, 2024
  • 32
  • 2024/2025
  • Exam (elaborations)
  • Questions & answers
  • BLOCK 3 PMY 302 - DRUGS to KNOW
  • BLOCK 3 PMY 302 - DRUGS to KNOW
avatar-seller
PatrickKaylian
BLOCK 3 PMY 302 - DRUGS to KNOW
Desmopressin MOA - activates V2 receptors in the kidney's collecting ducts, reabsorbing water
into plasma and concentrating the urine (prevents water from leaving the body)



Octreotide Acetate and Lanreotide Therapeutic effects - suppresses GH hypersecretions, reduces
pituitary adenoma overgrowth, and normalizing levels of GH and IGF-1



Somatropin Drug Class - Synthetic recombinant human growth hormone




Somatropin/Somatrem dosing - Daily dosing dependent and adjusted to individual clinical
response and IGF-1 levels



Somatropin/Somatrem pharmacokinetics - Following SC injection, 80% of the drug will be
systemically available



Somatropin/somatrem results and monitoring - Response to GH therapy is measured every 3-6
months by height and bone age determinations



Somatropin/Somatrem Therapeutic use - Childhood Dwarfism/Growth hormone deficiency
disorders



Somatrem Drug class - Analog of GH; synthetic recombinant human growth hormone with Extra
amino acid noted in protein makeup



Somatrem MOA - Similar to somatropin



Octreotide Acetate and Lanreotide drug class - synthetic analogs of somatostatin

,Octreotide Acetate and Lanreotide MOA - acts identical to somatostatin to directly inhibit GH
release from the anterior pituitary which effectively decreases circulating GH and IGF-1 levels



Octreotide Acetate and Lanreotide Dosing - Long-acting depots allow for once-a-month IM dosing
due to gradual release formula (10-20 mg/4 weeks) T ½: 1-2 hours



Octreotide acetate/Lanreotide/Pegvisomant Use - Acromegaly/Gigantism Tx

Somatropin MOA - Identical in action and abilities like endogenous secreted GH (stimulating
proliferation of bone growth plates and increased linear bone growth, promotion of protein synthesis
throughout the body)



Pegvisomant Drug class - GH receptor antagonist



Pegvisomant MOA - Blocks actions of GH and reduces the levels of circulating IGF-1



Pegvisomant Dosing - daily SubQ injections; increases dose until serum IGF-1 levels are
maintained to be within the age-appropriate/normal range (usually within 12 months, pt. Will have
normal or next to normal levels of IGF-1)



Pegvisomant drug structure - Extremely similar protein structure to GH but acts as a receptor
antagonist



Bromocriptine/Cabergoline drug class - Dopamine Receptor Agonists



Bromocriptine/Cabergoline MOA - Decreases prolactin production and secretions by prolactin-
secreting pituitary tumors; mimics the actions of dopamine and causes inhibition of prolactin secretion



Bromocriptine/Cabergoline Pharmacokinetics - Orally Active and effective use in 80-85% of cases



Bromocriptine/Cabergoline Therapeutic effects - Reduces tumor size, suppresses galactorrhea and
restores normal ovulatory menstrual cycles

,Bromocriptine special consideration - Longer track record of safety in use and cheaper to produce
(DOC/more commonly used)



Cabergoline special consideration - Has higher reported affinity for D2 receptors



Desmopressin Drug Class - DDAVP/Vasopressin synthetic analog



Desmopressin compared to ADH - Longer noted serum T ½ compared to ADH (DDAVP t ½ = 75
min) (ADH t ½ = >10 min)



Desmopressin Structure - Almost identical to ADH except for D-Amino acid in chemical chain
sequence (ADH has L-Amino Acid) *NOTE: Has a greater selectivity for V2 receptors compared to typical
ADH*



Desmopressin Pharmacokinetics - Extremely potent drug; Tablet (0.1-0.2 mg) or nasal spray
(0.01mg)



Desmopressin Outcomes of DI - Excessive urine production controlled with 0.1mg/3x daily



Desmopressin Outcomes of Nocturnal Enuresis - 4 months of Tx (0.2-0.4mg/daily) will decrease
average wet nights from 10/week to 6-7/2 weeks



Pitocin Drug class - Synthetic Oxytocin



Pitocin MOA - Stimulates uterine contractions during labor to strength (typically used in
induction/emergency scenarios if birth is taking an extremely long time)



Pitocin Pharmacokinetics - Given IV at low doses; used in OB/GYN practice

, Hydrocortisone Drug class - glucocorticoid replacement therapy



Hydrocortisone MOA - mimics actions of cortisol (increasing gluconeogenesis, protein, and lipid
catabolism and body resistance response to stress)



Hydrocortisone Use - replacement therapies for both adrenal insufficiencies and anti-
inflammatory/immunosuppressive treatments (Glucocorticoid of choice in replacement tx since adverse
effects are minimized)



Hydrocortisone Pharmacokinetics - Short-acting drug ( t ½ 80 min that requires 2-3 doses/daily);
The highest dose is an admin in the morning and smaller doses are given in the evening to mimic natural
cortisol blood levels // Short-acting preps are preferred because they can be adjusted readily to reduce
adverse effects and Extra doses can be given for bodily stresses (infections, fever, injury)



Fludrocortisone Drug class - mineralocorticoid replacement therapy



Fludrocortisone MOA - mimics actions of aldosterone (salt retention and elimination of K+; raises
BP)



Fludrocortisone Use - Provides mineralocorticoid activity in replacement therapies for adrenal
insufficiencies



Fludrocortisone Pharmacokinetics - T ½ 18-36 hours (long-lasting) daily dose; dosing is tailored to
manage BP and fluid balances



Prednisone drug class - glucocorticoid replacement therapy



Prednisone MOA - mimics actions of cortisol (increasing gluconeogenesis, protein, and lipid
catabolism, and body resistance response to stress) and has high anti-inflammatory properties; low
doses and short term use is important to prevent HPA axis suppression

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller PatrickKaylian. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $7.99. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

76462 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$7.99
  • (0)
  Add to cart